Antihyperlipidemic Drugs: Hmg-Coa Reductase Inhibitors (Statins)
Antihyperlipidemic Drugs: Hmg-Coa Reductase Inhibitors (Statins)
Antihyperlipidemic Drugs: Hmg-Coa Reductase Inhibitors (Statins)
PCSK9 Inhibitors
PCSK9 is an enzyme that binds w/LDL and prevents it from being removed from the
blood
These inhibitors are monoclonal antibodies that block enzyme process and lower LDL
cholesterol
Alirocumab(Praluent)
Evolocumab(Repatha)
These drugs are given subcutaneously once/twice monthly but
expensive. Can have possible cognitive adverse reactions
New class LDL lowering drugs for pt w/genetic familial hyperlipidemia or if at very high-
risk cardiovascular disease.
Therapy for genetic familial hyperlipidemia begin w/diet mod and statin drugs.
Miscellaneous/Antihyperlipidemic
Niacin(Niaspan, Niacor)
Lowers blood lipid levels, used as adjunct therapy for lowering very high serum
triglyceride levels in pt who are at risk for pancreatitis/response to dietary mod is
inadequate
C/I in pt w/active peptic ulcer, hepatic dysfunction, arterial bleeding; used
cautiously w/renal dysfunction, high alcohol consumption, unstable angina, gout
Pt may experience moderate to severe, generalized flushing of skin, warm
sensation, and severe itching/tingling. Tinnitus also may be a concern.
Notify HCP if skin reaction is severe/cause extreme discomfort. Aspirin
(325mg) about 30 minutes before may be administered to reduce adverse
reactions w/niacin
Ezetimibe(Zetia)
Inhibits absorption of cholesterol in small intestine, leading to decreased
cholesterol in liver, typically use in combo w/other antihyperlipidemic/lipid lowering
treatment
Take at least 2 hour before or 4 hours after bile acid sequestrant. Notify HCP if
unusual muscle pain, weakness/tenderness, severe diarrhea, respiratory infections
C/I in pregnant or lactating
General adverse reactions include N/V/D, abdominal pain, severe/generalized flushing of skin,
warm sensation, severe itching/tingling
Notes
Falls R/T dizziness associated w/fibrates and statins.
Statins have been associated w/skeletal muscle effects leading to rhabdomyolysis
Rhabdomyolysis is a rare condition in which muscle damages results in release of muscle
cells contents into bloodstream, can precipitate renal dysfunction or ARF.
Monitor for unexplained muscle pain, muscle tenderness, weakness, especially
if w/fever or malaise. More likely to be observed in Asian pt, initial low starting dose of
rosuvastatin is recommended